These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

480 related articles for article (PubMed ID: 32573017)

  • 1. Global epidemiology of lean non-alcoholic fatty liver disease: A systematic review and meta-analysis.
    Lu FB; Zheng KI; Rios RS; Targher G; Byrne CD; Zheng MH
    J Gastroenterol Hepatol; 2020 Dec; 35(12):2041-2050. PubMed ID: 32573017
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Global prevalence, incidence, and outcomes of non-obese or lean non-alcoholic fatty liver disease: a systematic review and meta-analysis.
    Ye Q; Zou B; Yeo YH; Li J; Huang DQ; Wu Y; Yang H; Liu C; Kam LY; Tan XXE; Chien N; Trinh S; Henry L; Stave CD; Hosaka T; Cheung RC; Nguyen MH
    Lancet Gastroenterol Hepatol; 2020 Aug; 5(8):739-752. PubMed ID: 32413340
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lean-non-alcoholic fatty liver disease increases risk for metabolic disorders in a normal weight Chinese population.
    Feng RN; Du SS; Wang C; Li YC; Liu LY; Guo FC; Sun CH
    World J Gastroenterol; 2014 Dec; 20(47):17932-40. PubMed ID: 25548491
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Prevalence of Lean/Nonobese Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis.
    Shi Y; Wang Q; Sun Y; Zhao X; Kong Y; Ou X; Jia J; Wu S; You H
    J Clin Gastroenterol; 2020 Apr; 54(4):378-387. PubMed ID: 31651571
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative Burden of Metabolic Dysfunction in Lean NAFLD vs Non-lean NAFLD - A Systematic Review and Meta-analysis.
    Tang A; Ng CH; Phang PH; Chan KE; Chin YH; Fu CE; Zeng RW; Xiao J; Tan DJH; Quek J; Lim WH; Mak LY; Wang JW; Chew NWS; Syn N; Huang DQ; Siddiqui MS; Sanyal A; Muthiah M; Noureddin M
    Clin Gastroenterol Hepatol; 2023 Jul; 21(7):1750-1760.e12. PubMed ID: 35863685
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epidemiology of lean/non-obese nonalcoholic fatty liver disease in China: A systematic review and meta-analysis.
    Zhang J; Huang X; Dong L; Yang Y; Kong D
    Saudi Med J; 2023 Sep; 44(9):848-863. PubMed ID: 37717964
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term outcomes in lean and non-lean NAFLD patients: a systematic review and meta-analysis.
    Huang S; Bao Y; Zhang N; Niu R; Tian L
    Endocrine; 2024 Jul; 85(1):134-141. PubMed ID: 37253855
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The global epidemiology of NAFLD and NASH in patients with type 2 diabetes: A systematic review and meta-analysis.
    Younossi ZM; Golabi P; de Avila L; Paik JM; Srishord M; Fukui N; Qiu Y; Burns L; Afendy A; Nader F
    J Hepatol; 2019 Oct; 71(4):793-801. PubMed ID: 31279902
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical Characteristics and Metabolic Profiles of Non-Alcoholic Fatty Liver Disease (NAFLD) in Lean Patients and Their Comparison with Obese and Overweight NAFLD.
    Chakrabarty M; Jha AN; Sharma DJ
    J Assoc Physicians India; 2022 Apr; 70(4):11-12. PubMed ID: 35443531
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nonalcoholic Fatty Liver Disease in Lean Subjects: Associations With Metabolic Dysregulation and Cardiovascular Risk-A Single-Center Cross-Sectional Study.
    Semmler G; Wernly S; Bachmayer S; Wernly B; Schwenoha L; Huber-Schönauer U; Stickel F; Niederseer D; Aigner E; Datz C
    Clin Transl Gastroenterol; 2021 Apr; 12(4):e00326. PubMed ID: 33821832
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analyzing and evaluating the prevalence and metabolic profile of lean NAFLD compared to obese NAFLD: a systemic review and meta-analysis.
    Fatima H; Sohail Rangwala H; Mustafa MS; Shafique MA; Abbas SR; Sohail Rangwala B
    Ther Adv Endocrinol Metab; 2024; 15():20420188241274310. PubMed ID: 39234426
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Global prevalence of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in the overweight and obese population: a systematic review and meta-analysis.
    Quek J; Chan KE; Wong ZY; Tan C; Tan B; Lim WH; Tan DJH; Tang ASP; Tay P; Xiao J; Yong JN; Zeng RW; Chew NWS; Nah B; Kulkarni A; Siddiqui MS; Dan YY; Wong VW; Sanyal AJ; Noureddin M; Muthiah M; Ng CH
    Lancet Gastroenterol Hepatol; 2023 Jan; 8(1):20-30. PubMed ID: 36400097
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lean non-alcoholic fatty liver disease and associated metabolic disturbance: A Saudi Arabian cross-sectional study.
    Khayyat YM
    Physiol Rep; 2021 Jul; 9(14):e14949. PubMed ID: 34278728
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lean nonalcoholic fatty liver disease and risk of incident type 2 diabetes mellitus: A literature review and meta-analysis.
    Gao Y; Zhao T; Song S; Duo Y; Gao J; Yuan T; Zhao W
    Diabetes Res Clin Pract; 2023 Jun; 200():110699. PubMed ID: 37169306
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk of Cardiovascular Disease in Individuals With Nonobese Nonalcoholic Fatty Liver Disease.
    Arvind A; Henson JB; Osganian SA; Nath C; Steinhagen LM; Memel ZN; Donovan A; Balogun O; Chung RT; Simon TG; Corey KE
    Hepatol Commun; 2022 Feb; 6(2):309-319. PubMed ID: 34558862
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolic risk factors and incident advanced liver disease in non-alcoholic fatty liver disease (NAFLD): A systematic review and meta-analysis of population-based observational studies.
    Jarvis H; Craig D; Barker R; Spiers G; Stow D; Anstee QM; Hanratty B
    PLoS Med; 2020 Apr; 17(4):e1003100. PubMed ID: 32353039
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Liver and Cardiovascular Damage in Patients With Lean Nonalcoholic Fatty Liver Disease, and Association With Visceral Obesity.
    Fracanzani AL; Petta S; Lombardi R; Pisano G; Russello M; Consonni D; Di Marco V; Cammà C; Mensi L; Dongiovanni P; Valenti L; Craxì A; Fargion S
    Clin Gastroenterol Hepatol; 2017 Oct; 15(10):1604-1611.e1. PubMed ID: 28554682
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gastrointestinal cancers in lean individuals with non-alcoholic fatty liver disease: A systematic review and meta-analysis.
    Souza M; Diaz I; Barchetta I; Mantovani A
    Liver Int; 2024 Jan; 44(1):6-14. PubMed ID: 37833849
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adiponectin-leptin ratio for the early detection of lean non-alcoholic fatty liver disease independent of insulin resistance.
    Lu CW; Yang KC; Chi YC; Wu TY; Chiang CH; Chang HH; Huang KC; Yang WS
    Ann Med; 2023 Dec; 55(1):634-642. PubMed ID: 36790383
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Global Prevalence of Nonalcoholic Fatty Liver Disease: An Updated Review Meta-Analysis comprising a Population of 78 million from 38 Countries.
    Amini-Salehi E; Letafatkar N; Norouzi N; Joukar F; Habibi A; Javid M; Sattari N; Khorasani M; Farahmand A; Tavakoli S; Masoumzadeh B; Abbaspour E; Karimzad S; Ghadiri A; Maddineni G; Khosousi MJ; Faraji N; Keivanlou MH; Mahapatro A; Gaskarei MAK; Okhovat P; Bahrampourian A; Aleali MS; Mirdamadi A; Eslami N; Javid M; Javaheri N; Pra SV; Bakhsi A; Shafipour M; Vakilpour A; Ansar MM; Kanagala SG; Hashemi M; Ghazalgoo A; Kheirandish M; Porteghali P; Heidarzad F; Zeinali T; Ghanaei FM; Hassanipour S; Ulrich MT; Melson JE; Patel D; Nayak SS
    Arch Med Res; 2024 Sep; 55(6):103043. PubMed ID: 39094335
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.